Trial intelligence / Profile preview

CHF6467 in Diabetic Foot Ulcers

NCT04077671Phase 2Completed

Sponsor
Chiesi Farmaceutici S.p.A.
Start
Oct 2018
Primary completion
Jan 2021
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of CHF6467 in diabetic foot ulcer (DFU), sponsored by Chiesi Farmaceutici S.p.A.. Started Oct 2018; status: completed.

02

Drugs

CHF6467
03

Conditions

diabetic foot ulcer (DFU)

Beyond the preview

Go deeper on NCT04077671.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04077671.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call